SEC Waives $40M Fine For Mallinckrodt In Medicaid Scheme
The U.S. Securities and Exchange Commission announced Thursday that it has waived a $40 million civil penalty against pharmaceutical company Mallinckrodt for overcharging Medicaid for one of its flagship drugs, saying...To view the full article, register now.
Already a subscriber? Click here to view full article